Most of our knowledge conceming the role of the blood-retinal barrier in human retinal disease has been derived through the clinical use of fluorescein angiography. A direct correlation between fluorescein 'leakage' and breakdown of the bloodretinal barrier has been established by the work of Cunha-Vaz and Maurice (I967) who demonstrated an active transport of fluorescein at the bloodretinal barrier level.
Most of our knowledge conceming the role of the blood-retinal barrier in human retinal disease has been derived through the clinical use of fluorescein angiography. A direct correlation between fluorescein 'leakage' and breakdown of the bloodretinal barrier has been established by the work of Cunha-Vaz and Maurice (I967) who demonstrated an active transport of fluorescein at the bloodretinal barrier level.
Fluorescein angiography, is not quantitative, and shows low sensitivity and reproducibility in assessing fluorescein permeability. A clinical quantitative method for the study of the blood-retinal barrier has been developed and is reported in this paper.
An alteration of the blood-retinal barrier has been proposed (Ashton, I965; Cunha-Vaz, 1966 , 1972  Norton and Gutman, I967) as one of the earliest retinal changes in diabetes. The development of the technique of vitreous fluorophotometry prompted us to examine a series of diabetic patients, particularly those who failed to show any retinal lesions with other methods of fundus examination.
Material and methods

VITREOUS FLUOROPHOTOMETRY
To measure the fluorescein concentration in the vitreous, a model 360 Haag-Streit slit lamp was modified by adapting a new source of illumination, appropriate filters, a photometric detection system similar to that described by Waltman and Kaufman (1970) for the examination of the anterior chamber, and a device for electrical registration of the movement of the instrument.
the removable exciting filter was mounted on the arm in front of the light source. The lamp and microscope arms were locked at an angle of 200 for measurements.
Microscope
The photometric detection systemt consisted of a modified eyepiece containing a fibreoptic probe, so designed that it could be superimposed on any area of the image of the optical cross-section, connected to a photomultiplier tube (EMI 9502), an autoranging photometer (2900), and either a recorder (500 XY) or an oscilloscope with storage (Tektronix 5103N5AI8N5B ioN) (Fig. i) . The sensor tip of the probe, which was 0I5 mm in diameter, focused simultaneously with the optical section, thus allowing the fluorescein concentration to be measured in all parts of the eye visible in the ocular of the slit lamp. The overall sensitivity of the instrument could be varied by adjusting the voltage across the photomultiplier tube while a standard solution of fluorescein was observed. The instrument has been shown to be stable after an initial warm-up period of about 30 minutes.
As the instrument scanned, it registered electrically by a system similar to that described by Kaiser and Maurice (I964) . A linear carbon potentiometer was clamped to the slit-lamp table and a sliding contact was moved by a rod held against the base of the instrument. The output from the potentiometer was brought to the X plates of the recorder. A manual switch was placed in line with the Y terminal of the recorder to mark the positions of the retinal and lens surfaces. All the measurements were made after application of a Worst lowvacuum contact lens to the eye under examination.
The filters used were either a Haag-Streit blue filter (T = 460 nm) or a Balzer FITC-3 (T = 46o-480 nm), with a red suppression filter as excitor and an Ilford io as barrier. The instrument was operated in a darkened room.
As the recording was normally done quickly it was not difficult for the patient to maintain a steady fixation. However, to standardize the procedure, the macular region was selected for recording. The recordings were finally transferred to fluorescein concentration curves, by dividing the recording into three equal parts, which were ascribed to posterior vitreous, middle vitreous, and anterior vitreous, taking the value from six equidistant points of each third of the recording and then extrapolating each of these values. Group II (diabetic patients without apparent retinal involvement) comprised 30 patients with confirmed diabetes, who are being followed-up in the diabetes clinic of the University Hospital of Coimbra. These cases were chosen because the retina was apparently normal. They had io/io visual acuity, and normal ophthalmoscopic, slit lamp, and fluorescein angiographical examinations. The discovery of any retinal vascular lesions, haemorrhages, or exudates automatically excluded the patient from the series.
Group III (diabetic retinopathy) included I5 diabetic patients showing different stages of diabetic retinopathy as shown by ophthalmoscopy, slit-lamp examination, and fluorescein angiography.
REPRODUCIBILITY OF THE METHOD
To test the reproducibility of the measurements obtained and to examine the possibilities of using this technique in longitudinal studies, three normal volunteers, three diabetic patients without retinopathy, and three diabetics with retinopathy were tested three times at 4-day intervals.
Results
The calibration and linearity of the response of the instrument were measured using standardized solutions in glass test-tubes. The instrument gives linear response to fluorescein concentrations between i X io-9 and approximately 5 X I50 g/ml (Fig. 2) . The sensitivity of the instrument could be increased by higher voltages being applied, although there would be increased random fluctuations in the noise output from the multiplier tube. To avoid these and obtain steady readings and recordings, a setting value of 888 V was chosen. The threshold at which fluorescein can no longer be measured in the various media of the eye is not limited by the sensitivity of the fluorophotometer but by the diffusion of light, by the tissues themselves, or by their autofluorescence. The vitreous body is itself sufficiently clear to allow fluorescein to be determined at concentrations below Io-9 g/ml. However, interference from the lens and the retina raised this threshold at the boundaries of the vitreous body, particularly in the proximity of the lens.
VALIDITY OF THE METHOD
When a small volume of fluorescein, IO 0d, was injected into the vitreous of a rabbit eye, the fluorophotometric recording taken io minutes after the intravitreal injection showed the gaussian distribution (Fig. 3) tment at the time of diabetic parameters, the visual acuity, and the relative incidence of their main lesions with the results of vitreous fluorophotometry. Group III-Diabetic retinopathy The eyes of the i5 diabetic patients included in this group showed clear evidence of diabetic retinopathy, from simple microaneurysms and a few haemorrhages and exudates to very advanced lesions with marked capillary closure, preferential channels, and neovessel formation. The recordings obtained from these eyes showed much higher values of fluorescein in the vitreous, usually of the order of 2 X Io-7 g/ml (Figs 6 and 7), but sometimes reaching values as high as 4 X I0o g/ml (Figs 8 and 9 ). In Table II Another aspect which appears to be of great interest in regard to the future use of vitreous fluorophotometry in diabetes (bearing in mind its sensitivity and reproducibility) is its use as an accurate clinical test of permeability changes during the course of the disease.
It appears that it is now possible to keep a close watch on the development and evolution of the breakdown of the blood-retinal barrier in diabetic retinopathy. This allows for the first time much needed controlled studies on the effect of drugs and/ or diabetic control in the retinopathy of diabetes.
Summary
The blood-retinal barrier plays an important part in the processes of retinal pathophysiology. A new clinical method for the study of the bloodretinal barrier by vitreous fluorophotometry appears to satisfy the necessary requirements in that it is quantitative and shows good reproducibility and high sensitivity.
The application of this method to a series of diabetic patients with apparently 'normal' fundi revealed the presence of a significant breakdown of the blood-retinal barrier in the early stages of retinal involvement in diabetes. The extent of the breakdown can be measured allowing for comparative and evolutionary evaluations. The disturbance of the blood-retinal barrier, as evidence by vitreous fluorophotometry, appears before microaneurysms or capillary closure can be demonstrated by fluorescein angiography.
